With new diagnostics and emerging therapies converging, Alzheimer’s disease care is shifting from late-stage symptom management to earlier intervention, says Lynn Kramer head of Clinical Research at global pharmaceutical company Esai. Continue →

In its ideal state, primary care strengthens population health, enhances quality of life and extends life expectancy. Continue →